Pre Market Brief for Thursday July 9th 2020

You can subscribe to the daily 4:00 AM Pre Market Brief on The Twitter Link Here . Alerts in the tweets will direct you to the daily 4:00 AM Pre Market Brief in this sub.

Updated as of 7:01 AM EST


Stock Futures:

  • Premarket Trading
  • Stock futures add to gains in late trading, after Nasdaq hits record high
  • Stock futures steady after Nasdaq clinches new record

Wednesday 07/08/2020 News and Markets Recap:

Thursday July 9th 2020 Economic Calendar (All times are in EST)

News Heading into Thursday July 9th 2020:

  • Weekly Jobless Claims total 1.314 million, vs 1.39 million estimate
  • Stocks making the biggest moves premarket: Walgreens, Square, Carnival, Six Flags, Alibaba & more
  • Ping Identity (PING) Announces Upsize and Pricing of Follow-on Offering of Common Stock by Selling Shareholders
  • Optinose (OPTN) Announces XHANCE Co-Promotion Agreement with Kaléo
  • FDA Approves Oral Therapy for Myelodysplastic Syndromes, CMML
  • Daily on Energy: Why the largest producer of zero-carbon electricity hasn’t set a 2050 goal
  • Coronavirus demand destruction cuts U.S. LNG exports to 13-month low
  • Nanoviricides Commences Underwritten Public Offering of Common Stock
  • Circle K owner may sell gas stations amid concerns over Speedway deal
  • Ares Capital Corporation (ARCC) Prices Public Offering of $750.0 Million 3.875% Unsecured Notes Due 2026
  • Qualigen Therapeutics, Inc. Announces $8 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
  • United Airlines sending layoff warnings to nearly half of its US employees
  • Bed Bath and Beyond Earnings: BBBY Stock Falls 10% on Poor Q1 Performance
  • Alcoa (AA) launches private debt offering
  • AnaptysBio (ANAB) Announces Orphan Drug Designation of Imsidolimab For Treatment of Generalized Pustular Psoriasis
  • Havertys Reports Sales for Second Quarter (Much Lower than Analyst Expectations)
  • Weatherford signs four-year contract with ENI S.P.A OTCPK:WFTLF
  • Zymeworks Snags $187 Million Deal With Merck & Co., Inc. to Discover Multi-Pronged Antibodies
  • Veritone Improves Revenue and Non-GAAP Net Loss Guidance for the Second Quarter of 2020
  • Turning Point Brands (TPB) Announces Pricing of Secondary Offering of Two Million Shares of Common Stock by its Significant Stockholders
  • Otonomy Announces (OTIC) Proposed Public Offering
  • 1-Airbus H1 (EADSY) deliveries hit 16-yr low despite June bounce
  • Energy Transfer Vows to Keep Pipeline Open After Court Order
  • Gilead begins testing inhalable form of remdesivir for COVID-19
  • Total TOT secures $15.8 billion in funding for Mozambique gas project: FNB
  • Melvin Capital Management LP Reports 5.8% Passive Stake In Avis Budget Group
  • Google Scrapped Cloud Initiative in China, Other Markets
  • Ealixir (BUDT) Announces Reverse Stock Split and New Trading Symbol
  • New Mexico fines Denver-based firm $5.3M for air pollution
  • Will likely Amazon Or Netflix Buy A Movie Theater Chain?
  • Jobless claims: Another 1.38 million Americans expected to have filed for unemployment benefits
  • United eyes mass layoffs as coronavirus creates 'worst crisis' in airline history
  • Tesla stock is a gigantic bubble on the verge of exploding: strategist
  • 'Scary Number of retail companies are facing bankruptcy amid the coronavirus pandemic
  • NanoViricides Prices $10.0 Million Underwritten Public Offering of Common Stock
  • Burger King UK to shed up to 1,600 jobs
  • Pressure mounts on Johnson and Johnson to halt global talc sales
  • Bed Bath and Beyond to close 200 stores over 2 years as sales fall almost 50% during pandemic
  • Tesla 'very close' to level 5 autonomous driving technology, Musk says
  • Mylan and Fujifilm Kyowa Kirin Biologics Announce U.S. FDA Approval of Hulio® (adalimumab-fkjp)
  • Hexo’s stock soars, after first medical cannabis sales outside of Canada
  • HealthEquity Announces Pricing of Public Offering of Common Stock
  • FDA Grants Priority Review to Merck’s Supplemental Biologics License Application for KEYTRUDA® (pembrolizumab) for Second-Line Treatment of Patients With Relapsed or Refractory Classical Hodgkin Lymphoma

Upcoming Earnings:


COVID-19 Stats and News:

Macro Considerations:

Most Recent SEC Filings



Morning Research and Trading Prep Tool Kit

Other Useful Resources:

The Ultimate Quick Resource For the Amateur Trader.

Subscribe to This Brief and the daily 4:00 AM Pre Market Brief on The Twitter Link Here . Alerts in the tweets will direct you to the daily brief in this sub

submitted by /u/Cicero1982

Source link

قالب وردپرس


Please enter your comment!
Please enter your name here